Skip to main content
. 2016 Nov 1;7(48):79141–79153. doi: 10.18632/oncotarget.13003

Figure 9. Storage of lipid droplets (LDs) was higher after treatment with sorafenib (A, B).

Figure 9

In sorafenib resistant cells, treatment with sorafenib did not overtly change LD levels (C, D). Data represent three independent experiments. *P < 0.01 versus 786-O dealing with sorafenib at 5 μmol/L; #,øP < 0.01 versus 786-O-R + ubenimex. Data represent three independent experiments. *P < 0.01 versus 786-O dealing with sorafenib at 5 μmol/L; #,øP < 0.01 versus 786-O-R + ubenimex (E, F).